Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 3

1(12.5%)

8Total

N/A(7)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06433596Not ApplicableActive Not Recruiting

Autologous PRP and Focal Shock Waves for Erectile Dysfunction

Role: collaborator

NCT03596047Not ApplicableCompleted

Radial Shockwave Therapy for Erectile Dysfunction

Role: lead

NCT06425211Not ApplicableRecruiting

Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.

Role: lead

NCT04207723Not ApplicableRecruiting

Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation

Role: lead

NCT06425224Phase 3Recruiting

Effectiveness and Safety of TENS Therapy for Premature Ejaculation

Role: lead

NCT03204890Not ApplicableCompleted

TPTNS for Treating Patients With Premature Ejaculation

Role: lead

NCT03308409Not ApplicableCompleted

Comparative Effectiveness and Safety of Three Protocols Usin Li-ESWT for Erectile Dysfunction

Role: lead

NCT03237143Terminated

Low-intensity Extracorporeal Shock Wave for Erectile Disfunction

Role: lead

NCT02683044Not ApplicableUnknown

Effectiveness And Safety Of Two Protocols For The Treatment Of Erectile Dysfunction With Low-Density Shock Waves

Role: collaborator

All 9 trials loaded